HealthcareServices

Global Cancer Biopsy Industry Insights: Key Trends and Growth Estimates

February 20, 2026February 23, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the cancer biopsy market from 2026–2035 with trusted insights from The Business Research Company

Starting from its 2026 valuation, what market size is the Cancer Biopsy Market expected to reach by 2030?

The cancer biopsy market size has experienced swift expansion in recent years. It is projected to increase from $28.52 billion in 2025 to $32.41 billion by 2026, achieving a compound annual growth rate (CAGR) of 13.6%. The historical growth of this market can be attributed to factors such as the increasing global cancer incidence, the expansion of diagnostic imaging facilities, the widespread adoption of tissue biopsy as a standard diagnostic practice, the growth of pathology laboratory networks, and improvements in biopsy device technologies.

The cancer biopsy market is projected to experience substantial expansion in the coming years. This market is forecast to reach $53.38 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 13.3%. This anticipated growth is driven by factors such as a heightened demand for precision oncology diagnostics, the growing acceptance of liquid biopsy testing, the broadening scope of personalized cancer treatment strategies, increased funding in molecular diagnostics, and a greater emphasis on detecting cancer in its early stages. Key trends anticipated during this period involve the increasing embrace of liquid biopsy methodologies, more frequent utilization of image-guided biopsy techniques, the expanding incorporation of molecular pathology assessments, the development of minimally invasive biopsy instruments, and a stronger emphasis on identifying cancer early.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=19355&type=smp

What Drivers Are Driving Adoption Within The Cancer Biopsy Market?

The rising incidence of cancer is anticipated to fuel the expansion of the cancer biopsy market. Cancer, a multifaceted group of illnesses, is distinguished by the uncontrolled multiplication and dissemination of cells. This rising cancer prevalence stems from various elements, including shifts in lifestyle and urbanization, environmental contamination, consumption of tobacco and alcohol, and improvements in healthcare availability and understanding. A cancer biopsy serves to diagnose and evaluate the cancer’s type, stage, and progression through the removal and examination of tissue or cells from a suspicious region. For illustration, in February 2024, data from the World Health Organization, a Switzerland-based intergovernmental organization, indicated that by 2050, more than 35 million new cancer cases are expected, marking a 77% surge over the approximate 20 million cases in 2022. Consequently, the growing occurrence of cancer is a key driver for the cancer biopsy market.

What Segments Are Included Within The Cancer Biopsy Market?

The cancer biopsy market covered in this report is segmented –

1) By Type: Tissue Biopsies, Liquid Biopsies, Other Types

2) By Application: Breast Cancer, Colorectal Cancer, Cervical Cancers, Lung Cancers, Prostate Cancers, Skin Cancers, Blood Cancers, Kidney Cancers, Other Applications

3) By End User: Hospitals, Diagnostic Laboratories, Other End Users

Subsegments:

1) By Tissue Biopsies: Core Needle Biopsies, Fine Needle Aspiration (FNA) Biopsies, Incisional Biopsies, Excisional Biopsies

2) By Liquid Biopsies: Circulating Tumor Cell (CTC) Analysis, Circulating Tumor DNA (ctDNA) Testing, Plasma Biomarker Testing

3) By Other Types: Bone Biopsies, Endoscopic Biopsies, Brush Biopsies, Skin Biopsies

What Trends Are Reshaping The Dynamics Of The Cancer Biopsy Market?

Major companies operating in the cancer biopsy market are advancing liquid biopsy techniques to enable non-invasive, early detection and monitoring of cancer, improve patient outcomes, and facilitate more personalized treatment approaches. Liquid biopsy is an sophisticated, non-invasive diagnostic method that identifies and analyzes genetic material from a blood sample, such as circulating tumor DNA (ctDNA), RNA, exosomes, and other biomarkers. For instance, in May 2023, Labcorp, a US-based company focused on manufacturing cancer biopsies, launched Labcorp Plasma Focus, a plasma-centric liquid biopsy designed to detect cancer-related biomarkers. The Plasma Focus test assesses circulating cell-free DNA (cfDNA) released from tumor cells into the bloodstream and can construct a genomic profile of the patient’s tumor, identifying mutations across 33 genes associated with various cancers, including non-small cell lung cancer, colorectal cancer, breast cancer, esophageal cancer, and melanoma.

Who Are The Major Companies Operating In The Cancer Biopsy Market?

Major companies operating in the cancer biopsy market are Thermo Fisher Scientific Inc., Danaher Corporation, Becton Dickinson and Company, Roche Diagnostics GmbH, Hologic Inc., Illumina Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., Exact Sciences Corporation, Myriad Genetics Inc., Guardant Health Inc., Veracyte Inc., GRAIL Inc., Freenome Holdings Inc., Biodesix Inc., Chronix Biomedical Inc., Biocept Inc., Personal Genome Diagnostics Inc., Agena Bioscience Inc., Oncimmune Holdings plc, Exosome Diagnostics Inc., Epigenomics AG, Genesystems Inc., Lucence Diagnostics Pte. Ltd., ANGLE plc

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/cancer-biopsy-global-market-report

Which Region Is Anticipated To See The Fastest Growth In The Cancer Biopsy Market?

North America was the largest region in the cancer biopsy market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cancer biopsy market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Cancer Biopsy Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=19355&type=smp

Browse Through More Reports Similar to the Global Cancer Biopsy Market 2026, By The Business Research Company

Breast Cancer Drugs Market Report 2026

https://www.thebusinessresearchcompany.com/report/breast-cancer-drugs-global-market-report

Skin Cancer Drugs Market Report 2026

https://www.thebusinessresearchcompany.com/report/skin-cancer-drugs-global-market-report

Pancreatic Cancer Drugs Market Report 2026

https://www.thebusinessresearchcompany.com/report/pancreatic-cancer-drugs-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795